Abstract Intravesical electromotive administration of local anesthetics is clinically successful but electrochemistry, cost and effectiveness limit the choice of drugs to diluted lidocaine HCl 4% mixed with epinephrine. These studies address the stability of lidocaine and epinephrine both over time and when exposed to electric current, i.e. transport rates with passive diffusion and electromotive administration. The drug mixture used was 50 ml lidocaine 4%, 50 ml H 2 O and 1 ml epinephrine 1/1000. For stability, the solution was placed either in bowls for 7 days or in a two chamber cell with the donor compartment (drugs) separated from the receptor compartment (NaCl solution) by a viable pig bladder wall. This was subjected to 30 mA for 45 min. Stability was measured with mass spectrometry. The cell was also used to determine transport rates with passive diffusion and currents of 20 mA and 30 mA, over 20, 30 and 45 min. Drug measurements in both compartments and bladder were made with HPLC. Lidocaine remained stable throughout the 7 days, epinephrine on day 1 only and both drugs were stable with 30 mA for 45 min. Comparing 20 mA and 30 mA with passive diffusion, there were significant differences in 6/6 donor compartment lidocaine levels, 4/6 receptor compartment levels and 6/6 bladder tissue levels and also in 6/6 epinephrine donor levels and 6/6 tissue levels. The combination lidocaine and epinephrine remains stable for 1 day and when exposed to 30 mA for 45 min. Electric current accelerates the transport of lidocaine and epinephrine.
Introduction
Lidocaine, introduced in 1948, is probably the most widely used local anesthetic today, with applications ranging from infiltration anesthesia to field blocks, epidural anesthesia, spinal anesthesia and intravenous regional anesthesia [14] . Almost all local anesthetic agents are practically insoluble in water but freely soluble in ethanol and many oils (lipids). Therefore, injectable lidocaine is supplied as the water-soluble, ionized hydrochloride salt (Ld + , Cl -) with a pH of 5-7. It has proved to be effective and safe for more than 50 years. However, when instilled intravesically, this formulation provides only superficial anesthesia [11, 16] because, with a pKa of 7.9 units, lidocaine is about 98% ionized at pH $6.0 and the permeability of urothelium to ionized polar molecules is very low [7] . Henry et al. buffered lidocaine HCl to pH $8.0 units with NaHCO 3 and achieved good penetration of the bladder wall with some 60% of the lidocaine present as the lipid-soluble, non-ionized base [6] .
Another approach that assists penetration of the urothelial barrier is electromotive administration. When electric current is applied to an aqueous solution, the delivery of solutes into underlying tissues is accelerated by at least three electrokinetic phenomena [1] . For ionized molecules the most important of these is iontophoresis, defined as: the active transport of ionized molecules by the application of an electric current of appropriate polarity through a solution containing the ions to be delivered. The normally random motion of the molecules is uniformly directed towards underlying tissues, their momentum is increased and drug administration rates can be calculated using equations derived from Faraday's law [10] . Numerous reports over decades attest to the efficacy of iontophoretic local anesthesia applied to the skin and tympanic membrane [1] , but only during the last 8 years has this approach been employed to provide adequate bladder anesthesia for transurethral resection of bladder tumor [4, 8, 9] and cystodistension [5, 13] . Because the bladder is both the target organ and the drug receptacle, there are certain unique constraints in addition to those normally associated with electromotive administration.
A generously perforated catheter containing the active electrode must be approximately centralized within the bladder to avoid biased delivery to the nearest section of bladder wall. For the same reason the bladder must be sufficiently distended to smooth out the rugal folds, with a 100 ml volume minimum [9] which provides a surface area ‡106 cm 2 , far larger than the usual area of skin anesthesia (8-10 cm 2 ). Therefore, electric current must be increased from the usual 2-4 mA to 15-30 mA in order to carry out treatment within a reasonable time frame of 15-30 min. As with all iontophoretic treatments, competing ions are to be avoided if at all possible. This causes difficulties because the great majority of injectable local anesthetics contain appreciable quantities of strongly competitive NaCl ions [4] . The exceptions are spinal anesthetic solutions, 100 ml of which are prohibitively expensive, and the inexpensive lidocaine HCl 4% in 50 ml vials, which is diluted down with sterile water [8] . Inflowing urine causes increasing ionic competition for electric current, therefore lidocaine 2%, rather than the otherwise effective 0.5%, is usually selected. Finally, the effect of lidocaine alone proved to be too short acting (15-20 min) , so epinephrine at an arbitrary 1/100,000 was added and the duration of anesthesia lengthened to a satisfactory 50-60 min [4, 9] . In spite of clinical success, several aspects of the intravesical electromotive administration of lidocaine and epinephrine when so mixed have not been clarified: (1) the stability of the two drugs both for hours or days following admixture as well as when electric current is applied; (2) comparative transport rates of lidocaine and epinephrine with passive diffusion and electromotive administration. This present laboratory study addresses these issues.
Materials and methods

Viable bladder sections
At a nearby abbattoir, pigs weighing 150±18 kg were killed using the standard technique of electronarcosis and incision of the great veins and arteries of the neck, and 15-20 min later the bladders were rapidly excised, placed in a cell culture medium (1·DMEM, HyClone Europe, Cramlington, UK) at 4°C and transported to the laboratory.
Drug solution
The drug solution in all experiments was the same as that used in clinical application: 50 ml lidocaine HCl 4% (NaCl-free), 1 ml epinephrine HCl 1/1,000 (1 mg/ml), 50 ml H 2 O which resolves to lidocaine 1.98% with epinephrine 1/101,000 (2% and 1/100,000 for all practical purposes).
Bench equipment
A battery-powered generator (Physion, Medolla, Italy) providing a programmable output of 1-30 mA (pulse) over programmable times of 1-45 min was used as the current source. Two silver plated spiral wires functioned as electrodes and were placed in a twochamber cell which separated the drug solution (donor compartment) from 100 ml NaCl 0.9% (receptor compartment) with a section of viable bladder wall (2.3-2.8 g) sealed without tension in the inter-compartmental window and exposing urothelium (area 1.8 cm 2 ) to the drug solution [2] .
Drug stability studies
To measure the duration of drug stabilities, the lidocaine and epinephrine mixture was placed in open steel bowls and stored for up to 7 days: (1) at room temperature with normal lighting, (2) at room temperature in the dark, and (3) at 4°C in the dark. On day 1, samples were taken at 2, 3, 4, 5, 6 and 8 h. On days 2-7, one sample was taken on each day. For electromotive administration, the drugs and NaCl solutions were placed in their respective compartments with the section of pig's bladder sealed in the window. Samples were taken from the donor compartment immediately prior to the application of electric current and following 30 mA for 45 min (total charge=1,350 mA min).
Measurements were performed with a bench-top triple-quadrupole mass spectrometer (Perkin-Elmer Sciex, Concord, Ontario, Canada) in the ion spray mode with an ionization probe operated at a sprayer voltage of 5,000 V. Data were acquired and processed using analyst software and instrument optimization was performed automatically using the autotune function included in the software. All data were acquired in the positive ion mode. Mass spectra were collected in continuous flow mode by connecting the built-in infusion pump directly to the ionspray probe and the solutions were infused at 10 ll/min. Lidocaine was dissolved in an aqueous solution of 50% methanol and 0.025% formic acid. Epinephrine was dissolved in an aqueous solution of 50% acetonitrile, 0.025% formic acid and 5 mM ammonium acetate.
Transport rates of lidocaine and epinephrine
With drug and NaCl solutions in their respective compartments and bladder wall in the window, passive diffusion was carried out for 2·4 samples taken from each compartment at 20, 30 and 45 min (n=24). Electromotive transport (positive polarity): four samples were taken from each compartment following 20 mA for 20 min, 30 mA for 20 min, 20 mA for 30 min, 30 mA for 30 min, 20 mA for 45 min, and 30 mA for 45 min (n=24).
Tissue samples were weighed and homogenized at room temperature for 1 min in PBS (1:3, w/v) using a Blendor homogenizer (30 ml capacity). The homogenate was then centrifuged at 10,000 g for 20 min at 4°C. The resulting supernatant was divided into two identical volumes for separate processing.
For lidocaine analysis, the sample (1 ml) was mixed with 10 ll (5 mg/ml) of bupivacaine as internal standard and extracted in the solid phase using 1 ml tubes of RP-C 18 preactivated in methanol and H 2 O. The tube was washed with three volumes of H 2 O/ methanol (3:1), the fraction containing lidocaine was eluted with 0.4 ml of 100% methanol and 100 ll of this sample was injected for HPLC analysis using a RP-C18 column. The chromatographic conditions were as follows: mobile phase, 10 mM pH 5.8 sodium phosphate buffer-acetonitrile (60:40 v/v); flow-rate, 1 ml/min; detection wavelength 203 nm; time 20 min. For epinephrine analysis, the sample (1 ml) was mixed with 40 ul of dihidroxylbenzylamine 10 lg/ml as internal standard and extracted as described in a catecholamine kit (ESA, Chelmsford, Mass.). Then 50 ul of sample was injected for HPLC analysis using a RP-C18 column Haisil 100 (150·4.6 mm). The chromatographic conditions were as follows: mobile phase, 90% buffer (0.05 M NaH 2 PO 4, 200 mg/l sodium dodecyl sulphate adjusted to pH 2.8) and 10% acetonitrile; detection electrochemical, electrode1 potential +0.25 V, electrode 2 potential )0.20 V; flow-rate, 1.4 ml/min; time 30 min.
Miscellaneous
The pH was measured in donor compartments before and after each experiment. The viability and structural features of tissue specimens were assessed with the trypan blue exclusion test and histological examination with H and E staining [2] .
Statistical analysis
All measurements were performed in duplicate. The data are means±SEM of replicates per group. Differences among group means (receptor and donor drug levels in compartments) were subjected to analysis of variance (ANOVA). Direct comparisons (tissue levels) were analyzed by Student's t-test.
Results
Drug stability
When stored in open bowls, lidocaine remained stable under all conditions from days 1-7 with CVs ranging from 2.9-9.3%. Epinephrine remained stable under all conditions during day 1 (CV range 2.2-2.9%) and for 7 days when stored at 4°C in the dark (CV 8.1%) but underwent significant degradation (CV 74-95%) over 7 days at room temperature. With the application of an electric current, both lidocaine and epinephrine remained stable when exposed to 30 mA for 45 min (Figs. 1, 2 ).
Lidocaine transport rates
The lidocaine content of the receptor and donor compartments for times 20, 30 and 45 min are shown in Table 1 . With the application of both 20 and 30 mA, the lidocaine levels in all donor compartments were significantly less than the corresponding levels following passive diffusion, whereas receptor compartment levels following 20 mA for 30 min and 30 mA for 20, 30 and 45 min were significantly higher. Taking the corresponding donor/receptor ratios of lidocaine levels, those following electromotive administration exceeded those following passive diffusion by factors averaging 11:1 with 20 mA and 13:1 with 30 mA (3:1-28:1). In bladder tissues, all lidocaine levels following all electromotive experiments significantly exceeded the corresponding levels following passive diffusion experiments (Table 1 and Fig. 3) . The ratio of tissue lidocaine levels, electromotive administration/passive diffusion, was 6:1 (3:1-10:1).
Epinephrine transport rates
Epinephrine was not detected in any of the receptor compartment samples. All donor compartment epinephrine levels following electromotive administration were significantly lower than the corresponding levels following passive diffusion (Table 2, Fig. 4 ). All tissue levels following electromotive administration significantly exceeded those following passive diffusion and tissue level ratios, electromotive/passive diffusion, averaged 9:1 (4:1-12:1).
Miscellaneous
Values for pH averaged 6.0 units before and 6.1-6.4 units after the experiments. There was no trypan blue staining of epithelial, subepithelial or muscle cells, indicating the viability of tissues throughout the experiments. Histological examination of the bladder wall specimens showed a normal structure (Fig. 5A, B) .
Discussion
The availability of local anesthetic solutions at a reasonable price and free of the competitive quantities of NaCl reduce intravesical electromotive options to 50 ml vials of lidocaine HCl 4% diluted down with sterile water and the addition of epinephrine at an arbitrarily selected 1/100,000 concentration. Although the two drugs are chemically compatible, this particular mixture raised issues that had to be resolved.
Lidocaine is very stable under a wide variety of conditions and problems were neither anticipated nor found. However, the 1 ml ampuls of epinephrine are sealed under nitrogen and contain Na bisulphite to prevent oxidation. Therefore, when mixed with lidocaine and exposed to the atmosphere with Na bisulphite diluted 100-fold, it is simply a question of time before epinephrine is significantly degraded. Another issue is the possible deleterious effect of electric current, although clinical experience has indicated that this is unlikely. Our results resolved two practical issues. First, a solution of lidocaine and epinephrine optimized for iontophoretic administration should be mixed on the day of use and any remainder discarded. Second, both drugs remain stable when subjected to a total charge of 1,350 mA min, about twice the maximum, 600-700 mA min, used for intravesical procedures [4, 8] .
During passive diffusion, lidocaine did not appear subject to Fick's first law, with quantities in the compartments and in tissues displaying no obvious relationship to time elapsed. A diminishing concentration gradient is not the answer (Table 1) , so possibly the diffusion coefficient (D L ) for lidocaine is not a constant but a variable that declines with time because, following initial uptake, ionized lidocaine stabilizes the urothelial membrane [15] and creates a conformational barrier to further uptake. Conversely, epinephrine levels in tissues showed an almost linear increase with time in spite of its very low concentrations and the technical difficulties 
associated with measurement. This is intriguing, as both lidocaine and epinephrine have similar molecular weights (234 Da and 183 Da, respectively), they share certain chemical characteristics-a hydrophobic aromatic residue and a hydrophilic amine group-and both were in ionized form.
With the application of an electric current, lidocaine again demonstrated aberrant behaviour. Other ions in solution offered negligible competition and quantities of lidocaine transported from time zero through 20 and 30 min appeared to increase linearly in accordance with simple electrochemistry (Appendix). But the amount of lidocaine transported at 45 min was less than that at 30 min at both 20 mA and 30 mA, an aberration for which we have no explanation. Conversely, the very dilute epinephrine, totally outmatched by charge competition from all other ions in solution, demonstrated (Fig. 4) , so after about 20 min epinephrine continues to accumulate in tissues without further transformation and measured quantities rise more steeply from 20-45 min. Finally, bladder wall is remarkably resilient when exposed to high current densities. In these present studies, maximum current densities were 30 mA/ 1.8 cm 2 =16.7 mA/cm 2 applied for 45 min, and no tissue damage was detected histologically or by the trypan blue test. Conversely, the maximum recommended for human skin [1] is 0.5 mA/cm 2 ; current densities of 1.0 mA/cm 2 are distinctly uncomfortable and often result in small punctate burns; current densities ‡5 mA/cm 2 rapidly (5-10 min) cause severe damage to the skin whether in vivo or in a laboratory cell. Almost certainly this difference is due to structural differences between the two tissues. Skin is inhomogeneous with numerous small perforations (hair follicles, sweat ducts) of lower electrical resistance tending to focus the current which causes burns. The bladder wall, especially the urothelium, is structurally homogeneous so that applied current is evenly dispersed over the whole exposed area. Nevertheless, the absence of microscopic tissue damage or death does not imply that there are no functional changes. Simple calculations reveal that the ratio of measured quantities (M L ) of lidocaine transported (Table 1) to quantities (T L ) calculated theoretically (Appendix), M L :T L =2.3:1 (1.4:1-3.7:1) which indicates an increased permeability of the tissues under the influence of an electric current [12] , thereby increasing the passive diffusion component.
In conclusion, lidocaine HCl 4% (NaCl-free) in 50 ml vials, diluted with water to 2% and mixed on the day of use with epinephrine (final concentration 1/100,000) provides an electrochemically favorable, inexpensive, local anesthetic solution for intravesical electromotive administration. Electric currents of 20 and 30 mA increased administration rates of both lidocaine and epinephrine by factors of 6:1-13:1 and 9:1 respectively as compared to administration rates with passive diffusion. These quantitative studies provide pharmacologic, in vitro support for the results reported in clinical studies using electromotive administration of this drug combination. Just as importantly, the studies of epinephrine stability define a time limit of 1 day between mixing and application of the drug combination; failure to observe this limit will lead to suboptimal clinical results.
